NCT05503550 2025-12-16Pre-Approval Access Single Patient Request for Talquetamab in Relapsed or Refractory Multiple MyelomaJanssen Research & Development, LLCNo longer available
NCT05918913 2025-09-05Expanded Access Program for RevumenibSyndax PharmaceuticalsNo longer available3 FDA